Stock Analysis·← Pickers

LITS

Lite Strategy, Inc.

Lite Strategy, Inc. (LITS) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 56.3, with 1/3 trend checks passing.

Price
$0.99
+0.00 (+0.42%)
Day range
$0.96–$1.01
52wk $0.69–$9.00
Volume
12.5K
Avg
Trend score
1/3
Range / Mixed
RSI (14)
56.3
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

LITS with MA50 and MA200

4.533.582.631.690.7409/0311/1802/0904/2807/16
LITS2025-09-032026-07-16
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.98+2.55% vs price
MA200
$1.38-27.40% vs price
RSI (14)
56.3Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Valuation

LITS valuation multiples (TTM)

P/E Ratio
P/S Ratio
P/B Ratio
EV/EBITDA
Valuation multiples are provided by Financial Modeling Prep when available.
Analyst Ratings

LITS analyst consensus

Avg Price Target
High Target
Low Target
Analyst Coverage
Analyst ratings and price targets are provided by Financial Modeling Prep when available.
Chart Summary
Trend summary for LITS

Lite Strategy, Inc. (LITS) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $0.99, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 2.5% and below the 200-day moving average by 27.4%.

Momentum and stretch context

LITS currently has an RSI reading of 56.3, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the LITS chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Lite Strategy, Inc.

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

Sector
Healthcare
Industry
Asset Management - Cryptocurrency
CEO
Justin J. File
Employees
4
Market cap
$33.1M
Beta
0.05
52-week range
$0.69 – $9.00
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
18 Dec 2003
ISIN
US55279B3015
CUSIP
55279B301
Company profile data from Financial Modeling Prep. LITS listed on NASDAQ.
Share dilution

LITS shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Dec 2023Mar 2026
Shares outstanding (latest)
6.7M
Since Dec 2023
+0.0%
Trend
Roughly flat
Historical shares-outstanding data from Financial Modeling Prep. LITS10 data points from Dec 2023 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about LITS

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.